By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: Supernus Pharmaceuticals
Employees:
Symbol: SUPN
 



Industry
Pharmaceutical






Company News
Supernus Pharmaceuticals (SUPN) Announces Third Quarter 2014 Results 11/12/2014 7:54:47 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fourth U.S. Patent Protecting Trokendi XR® 11/7/2014 7:46:15 AM
Supernus Pharmaceuticals (SUPN) To Present At Two Investor Conferences 11/5/2014 10:10:42 AM
Supernus Pharmaceuticals (SUPN) To Host Third Quarter 2014 Earnings Conference Call 10/30/2014 8:05:53 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing For Trokendi XR(R) 10/14/2014 8:22:17 AM
Supernus Pharmaceuticals (SUPN) Sues Actavis (ACT) For Infringement Of Trokendi XR® Patents 10/2/2014 8:08:24 AM
Supernus Pharmaceuticals (SUPN) Provides Business Update 9/23/2014 7:40:57 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance of Fourth US Patent Protecting Oxtellar XR® 9/4/2014 9:16:05 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Trokendi XR® 8/21/2014 7:54:43 AM
Supernus Pharmaceuticals (SUPN) To Attend FBR Healthcare Conference In September 8/20/2014 7:34:14 AM
12345678
//-->